MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: BMNDF )

0.2500 UNCHANGED
Streaming Delayed Price Updated: 10:44 AM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2500
Today's Range 0.2500 - 0.2500
52wk Range 0.0887 - 0.5298
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
From Biomind Labs Inc.
Via Business Wire
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga

Performance

YTD
+150.00%
+150.00%
1 Month
+180.90%
+180.90%
3 Month
+180.90%
+180.90%
6 Month
+150.00%
+150.00%
1 Year
+150.00%
+150.00%

More News

Read More
Psychedelic Stock Gainers And Losers From January 26, 2023
Via Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
Via Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
Via Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Via Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
Via Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
Via Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Via Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Via Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
Via Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
Via Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story